Neuland Laboratories management to attend Nuvama UK Conference

0 min read     Updated on 03 Jun 2026, 03:09 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Neuland Laboratories Limited announced its management's participation in the Nuvama India Conference 2026 (UK Edition) in London on June 8 and 9, 2026. The company will hold group and one-on-one meetings with analysts and investors. The schedule is subject to change based on exigencies.

powered bylight_fuzz_icon
42025144

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories Limited has informed the stock exchanges that its management will participate in the Nuvama India Conference 2026 (UK Edition) scheduled for June 8 and 9, 2026. The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This engagement allows the company to present its outlook directly to analysts and institutional investors.

The event will take place in London, United Kingdom. The management is scheduled to conduct both group meetings and one-on-one sessions with attendees. The schedule and participant list remain subject to change due to exigencies on the part of the participants or the company.

The following table outlines the details of the participation:

Date Name of the Event Location Nature of Meeting
June 8 & 9, 2026 Nuvama India Conference 2026 (UK Edition) London, United Kingdom Group meet / One-on-One meet

Sarada Bhamidipati, Company Secretary of neuland laboratories , signed the intimation on June 3, 2026. The filing was submitted to BSE Limited and The National Stock Exchange of India Ltd for their information and records.

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%+0.52%+12.38%-0.67%+42.65%+691.55%

What strategic growth initiatives does Neuland Laboratories plan to highlight during the conference?

How might the company's participation in the UK conference influence its investor base or attract foreign institutional investors?

What are the expected key takeaways regarding Neuland's financial outlook for the upcoming fiscal year?

Neuland management to meet investors on June 5

1 min read     Updated on 01 Jun 2026, 05:34 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Neuland Laboratories Limited announced that its management will participate in a group analyst and institutional investor meeting on June 5, 2026, in Hyderabad as part of the BOFA Healthcare Tour. The meeting will include group and one-on-one sessions to discuss performance and strategy. The disclosure was made under Regulation 30 of SEBI regulations.

powered bylight_fuzz_icon
41781379

*this image is generated using AI for illustrative purposes only.

Neuland Laboratories Limited has announced that its management will participate in a group analyst and institutional investor meeting on June 5, 2026. The meeting is part of the BOFA Healthcare Tour and will take place in Hyderabad. This engagement provides a platform for the company to interact with key market stakeholders and discuss its performance and strategy.

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was addressed to BSE Limited and The National Stock Exchange of India Ltd to ensure compliance with regulatory requirements.

The meeting format includes both group and one-on-one sessions, allowing for detailed discussions with participants. The company noted that the schedule and participant list are subject to change due to any exigencies on the part of the participants or the company.

Date Name of the Analyst / Institutional Investor / Event Location Nature of the meeting
June 5, 2026 BOFA Healthcare Tour Hyderabad Group meet / One-on-One meet

Sarada Bhamidipati, Company Secretary of Neuland Laboratories Limited, signed the intimation on May 31, 2026. The company's scrip codes are 524558 on BSE and NEULANLAB on NSE.

Historical Stock Returns for Neuland Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%+0.52%+12.38%-0.67%+42.65%+691.55%

What strategic priorities is Neuland Laboratories likely to highlight during the BOFA Healthcare Tour?

How might the investor meeting influence market sentiment and stock performance in the short term?

What potential partnerships or collaborations could emerge from the one-on-one sessions with institutional investors?

More News on Neuland Laboratories

1 Year Returns:+42.65%